Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
09.04. | Purmo Group Oyj: Resolutions of Purmo Group Plc's Annual General Meeting | 181 | GlobeNewswire (Europe) | Purmo Group Plc | Stock Exchange Release | April 09, 2024 at 15:45:00 EEST
Purmo Group Plc's Annual General Meeting was held today, Tuesday 9 April 2024 in Helsinki.The Annual General Meeting approved... ► Artikel lesen | |
09.04. | Mondelez International, Inc.: Mondelez International's Near-term 2030 Targets and 2050 Net-Zero Targets Validated by Science Based Targets Initiative | 855 | GlobeNewswire (Europe) | Approval reinforces Mondelez International's commitment to its mission to create a more sustainable snacking company CHICAGO, April 09, 2024 (GLOBE NEWSWIRE) -- Mondelez International, Inc. (Nasdaq:... ► Artikel lesen | |
09.04. | DGB Group N.V.: DGB Group achieves project milestone and receives €150,000 upfront payment | 180 | GlobeNewswire (Europe) | DGB Group N.V. ("DGB", "the Group", or "the Company") (Euronext: DGB: NL000916951), a leading carbon project developer and ecosystem restoration company, successfully manufactured and distributed its... ► Artikel lesen | |
09.04. | Kaixin Auto Holdings Announces Name Change | 201 | GlobeNewswire (Europe) | HANGZHOU, China, April 09, 2024 (GLOBE NEWSWIRE) -- Kaixin Auto Holdings ("Kaixin" or the "Company") (NASDAQ: KXIN) today announced that it has changed its legal name from Kaixin Auto Holdings to... ► Artikel lesen | |
09.04. | Halcones Precious Metals Inc.: Halcones Withdraws from Option to Acquire the Carachapampa Project in Chile | 112 | GlobeNewswire (Europe) | TORONTO, April 09, 2024 (GLOBE NEWSWIRE) -- Halcones Precious Metals Corp. (TSX - V: HPM) (the "Company" or "Halcones") has withdrawn from its option to acquire the Carachapampa project (the "Project")... ► Artikel lesen | |
09.04. | ALX Oncology Reports Encouraging Clinical Data of Evorpacept in Combination with Standard-of-Care in an Ongoing Phase 1/2 Clinical Trial in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma ("R/R B-NHL") | 142 | GlobeNewswire (Europe) | - Twenty patients with indolent (n=18) and aggressive (n=2) R/R B-NHL received evorpacept plus standard rituximab and lenalidomide ("R2")- Evorpacept plus R2 was well tolerated with a safety profile... ► Artikel lesen | |
09.04. | Movella Holdings, Inc.: Movella Announces Listing on OTC Pink Market | 387 | GlobeNewswire (Europe) | HENDERSON, Nev., April 09, 2024 (GLOBE NEWSWIRE) -- Movella Holdings Inc. (NASDAQ: MVLA) ("Movella" or the "Company"), a leading full-stack provider of sensors, software, and analytics that enable... ► Artikel lesen | |
09.04. | Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024 | 320 | GlobeNewswire (Europe) | Poster outlines the parameters for developing a flow-cytometry-based PPMP as a companion diagnostic to predict volasertib responders, based on a proof-of-concept study using 41 primary acute myeloid... ► Artikel lesen | |
09.04. | Prelude Therapeutics, Inc.: Prelude Highlights Continued Strength of Discovery Engine at 2024 AACR Annual Meeting | 96 | GlobeNewswire (Europe) | Highly selective oral SMARCA2 degrader, PRT7732, shows robust anti-tumor activity in vivo as monotherapy and in combination with chemotherapy, at well-tolerated doses Potentially best-in-class CDK9... ► Artikel lesen | |
09.04. | Jianzhi Education Technology Group Company Limited Reports Fiscal Year 2023 Financial Results | 217 | GlobeNewswire (Europe) | BEIJING, April 09, 2024 (GLOBE NEWSWIRE) -- Jianzhi Education Technology Group Company Limited (the "Company" or "Jianzhi") (NASDAQ: JZ), a leading provider of digital educational content in China... ► Artikel lesen | |
09.04. | Foghorn Therapeutics, Inc.: Foghorn Therapeutics Presents New Preclinical Data on Potential First-in-Class BRM Selective Inhibitor FHD-909 and Selective CBP and Selective EP300 Degrader Oncology Programs | 125 | GlobeNewswire (Europe) | First-in class BRM (SMARCA2) selective inhibitor FHD-909 demonstrated favorable tolerability and dose-dependent single agent activity in BRG1 mutated cancers preclinically; IND filing on track for... ► Artikel lesen | |
09.04. | IN8bio, Inc: IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024 | 188 | GlobeNewswire (Europe) | - Preclinical data supports potential for proprietary nsCAR platform to selectively eliminate cancer cells while preserving healthy tissue - Gamma-delta nsCAR platform emerging as an advanced technology... ► Artikel lesen | |
09.04. | Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to May 9, 2024 | 54 | GlobeNewswire (Europe) | New York, NY, April 09, 2024 (GLOBE NEWSWIRE) -- Globalink Investment Inc. (Nasdaq: GLLI, GLLIW, GLLIR, GLLIU) ("Globalink" or the "Company"), a special purpose acquisition company, announced today... ► Artikel lesen | |
09.04. | O-I Glass, Inc.: O-I Glass Drinktainer Enters RTD Market | 395 | GlobeNewswire (Europe) | Right Coast Spirits Italian Ice to be first brand packed in DrinktainerTM via O-I and FX Matt contract packing collaboration Release pairs the sleek, modern design of Drinktainer with refreshing... ► Artikel lesen | |
09.04. | Intrepid Potash, Inc: Intrepid Announces Accident Involving CEO | 203 | GlobeNewswire (Europe) | Denver, CO, April 09, 2024 (GLOBE NEWSWIRE) -- Intrepid Potash, Inc. ("Intrepid", "we," or "our") (NYSE:IPI) today announced that on Saturday, April 6, 2024, Bob Jornayvaz was involved in an accident... ► Artikel lesen | |
09.04. | Nasdaq, Inc.: Nasdaq Announces End of Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date March 28, 2024 | 152 | GlobeNewswire (Europe) | NEW YORK, April 09, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of March 28, 2024, short interest in 3,102 Nasdaq Global MarketSM securities totaled 11,297,406,980 shares compared with... ► Artikel lesen | |
09.04. | ImmuCell Corporation: ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024 | 179 | GlobeNewswire (Europe) | PORTLAND, Maine, April 09, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically... ► Artikel lesen | |
09.04. | Rakovina Therapeutics Inc: Rakovina Therapeutics Presented at American Association of Cancer Research Annual Meeting at the San Diego Convention Center Today | 107 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, April 09, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), ("Rakovina" or the "Company"), a biopharmaceutical company dedicated to improving the lives... ► Artikel lesen | |
09.04. | NeurAxis, Inc.: NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results | 171 | GlobeNewswire (Europe) | CARMEL, Ind., April 09, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic... ► Artikel lesen | |
09.04. | Shattuck Labs, Inc.: Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024 | 108 | GlobeNewswire (Europe) | - Aberrant TRIM7 expression identified as a key driver of immune checkpoint blockade (ICB) acquired resistance; inhibition of TRIM7 with small molecule inhibitors may prevent or reverse acquired resistance... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 1.682 |
NEL | 1.667 |
SUPER MICRO COMPUTER | 1.656 |
NVIDIA | 1.650 |
TUI | 1.484 |
BAYER | 1.336 |
RHEINMETALL | 1.000 |
RENK GROUP | 930 |
PROSIEBENSAT.1 | 912 |
VOLKSWAGEN | 735 |
AMAZON | 699 |
PALANTIR TECHNOLOGIES | 698 |
TESLA | 687 |
MICROSTRATEGY | 636 |
DEUTSCHE BANK | 585 |
PLUG POWER | 571 |
BASF | 565 |
BYD | 557 |
THYSSENKRUPP | 542 |
COMMERZBANK | 535 |
AIXTRON SE | 532 |
SAP | 507 |
MERCEDES-BENZ | 506 |
ALLIANZ | 493 |
DEUTSCHE TELEKOM | 473 |